United Nations High Commissioner for Refugees. UNHCR - Refugee Statistics. https://www.unhcr.org/refugee-statistics/. Accessed 2 Mar 2023.

van Zandvoort K, Checchi F, Diggle E, Eggo RM, Gadroen K, Mulholland K, et al. Pneumococcal conjugate vaccine use during humanitarian crises. Vaccine. 2019;37:6787–92.

Article  PubMed  Google Scholar 

Heudtlass P, Speybroeck N, Guha-Sapir D. Excess mortality in refugees, internally displaced persons and resident populations in complex humanitarian emergencies (1998–2012) – insights from operational data. Confl Health. 2016;10:15.

Article  PubMed  PubMed Central  Google Scholar 

Bellos A, Mulholland K, O’Brien KL, Qazi SA, Gayer M, Checchi F. The burden of acute respiratory infections in crisis-affected populations: a systematic review. Confl Health. 2010;4:3.

Article  PubMed  PubMed Central  Google Scholar 

O’Brien KL, Baggett HC, Brooks WA, Feikin DR, Hammitt LL, Higdon MM, et al. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet. 2019;394:757–79.

Article  Google Scholar 

Kohrt BA, Mistry AS, Anand N, Beecroft B, Nuwayhid I. Health research in humanitarian crises: an urgent global imperative. BMJ Global Health. 2019;4:e001870.

Article  PubMed  PubMed Central  Google Scholar 

Turner P, Turner C, Jankhot A, Helen N, Lee SJ, Day NP, et al. A longitudinal study of Streptococcus pneumoniae carriage in a cohort of infants and their mothers on the Thailand-Myanmar Border. PLoS ONE. 2012;7:e38271.

Article  CAS  PubMed  PubMed Central  Google Scholar 

WHO. Prequalified vaccines. Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control). 2019. https://extranet.who.int/pqweb/vaccines/prequalified-vaccines. Accessed 2 Mar 2023.

Pfizer. US, FDA Approves. PREVNAR 20™, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Older. 2021. https://www.pfizer.com/news/press-release/press-release-detail/us-fda-approves-prevnar-20tm-pfizers-pneumococcal-20-valent. Accessed 14 Sep 2021.

Merck. Merck Announces US. FDA Approval of VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Adults 18 Years and Older Caused by 15 Serotypes. 2021. https://www.merck.com/news/merck-announces-u-s-fda-approval-of-vaxneuvance-pneumococcal-15-valent-conjugate-vaccine-for-the-prevention-of-invasive-pneumococcal-disease-in-adults-18-years-and-older-caused-by-15-serot/. Accessed 14 Sep 2021.

Bogaert D, De Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4:144–54.

Article  CAS  PubMed  Google Scholar 

van Zandvoort K, Bobe MO, Hassan AI, Abdi MI, Ahmed MS, Soleman SM, et al. Social contacts and other risk factors for respiratory infections among internally displaced people in Somaliland. Epidemics. 2022;41:100625.

Article  PubMed  Google Scholar 

COPAN Diagnostics Inc. FLOQSwabs. https://www.copanusa.com/sample-collection-transport-processing/floqswabs/. Accessed 2 Mar 2023.

Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine. 2013;32:165–79.

Article  PubMed  Google Scholar 

Pell CL, Ortika BD, Van Zandvoort K, Wee-Hee A, Mulholland EK, Checchi F et al. Effect of transport conditions on recovery of Streptococcus pneumoniae. 2022.

THERMOCON. THERMOCON CLASSIC 15.5. https://thermocon-coldchain.com/en/produkt/thermocon-classic-15-5/. Accessed 2 Mar 2023.

Dunne EM, Murad C, Sudigdoadi S, Fadlyana E, Tarigan R, Indriyani SAK et al. Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: A cross-sectional study. PLOS ONE. 2018;13:e0195098.

Satzke C, Dunne EM, Choummanivong M, Ortika BD, Neal EFG, Pell CL, et al. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine. Vaccine. 2019;37:296–305.

Article  PubMed  Google Scholar 

Carvalho Mda, GS, Tondella ML, McCaustland K, Weidlich L, McGee L, Mayer LW, et al. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol. 2007;45:2460–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salter SJ, Hinds J, Gould KA, Lambertsen L, Hanage WP, Antonio M, et al. Variation at the capsule locus, cps, of mistyped and non-typable Streptococcus pneumoniae isolates. Microbiol (Reading). 2012;158:1560–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clarke E, Bashorun A, Adigweme I, Hydara MB, Umesi A, Futa A, Ochoge M, Obayemi D, Edem B, Saidy-Jah E, Onwuchekwa C. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Infect Dis. 2021;21(6):834–46.

Lumley T. Complex surveys: a guide to analysis using R. Wiley; 2011.

Lumley T, Gao P, Schneider B. survey: Analysis of Complex Survey Samples [R package]. Version 4.2. 2023. https://CRAN.R-project.org/package=survey

Løchen A, Truscott JE, Croucher NJ. Analysing pneumococcal invasiveness using bayesian models of pathogen progression rates. PLoS Comput Biol. 2022;18:e1009389.

Article  PubMed  PubMed Central  Google Scholar 

Qian G, Toizumi M, Clifford S, Le LT, Papastylianou T, Satzke C, et al. Association of pneumococcal carriage in infants with the risk of carriage among their contacts in Nha Trang, Vietnam: a nested cross-sectional survey. PLoS Med. 2022;19:e1004016.

Article  PubMed  PubMed Central  Google Scholar 

Neal EFG, Chan J, Nguyen CD, Russell FM. Factors associated with pneumococcal nasopharyngeal carriage: a systematic review. PLOS Glob Public Health. 2022;2:e0000327.

Article  PubMed  PubMed Central  Google Scholar 

le Polain de Waroux O, Flasche S, Kucharski AJ, Langendorf C, Ndazima D, Mwanga-Amumpaire J, et al. Identifying human encounters that shape the transmission of Streptococcus pneumoniae and other acute respiratory infections. Epidemics. 2018;25:72–9.

Article  Google Scholar 

Neal EFG, Flasche S, Nguyen CD, Ratu FT, Dunne EM, Koyamaibole L, et al. Associations between ethnicity, social contact, and pneumococcal carriage three years post-PCV10 in Fiji. Vaccine. 2020;38:202–11.

Article  PubMed  PubMed Central  Google Scholar 

Hill PC, Akisanya A, Sankareh K, Cheung YB, Saaka M, Lahai G, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis. 2006;43:673–9.

Article  PubMed  Google Scholar 

Nackers F, Cohuet S, le, Polain de Waroux O, Langendorf C, Nyehangane D, Ndazima D et al. Carriage prevalence and serotype distribution of Streptococcus pneumoniae prior to 10-valent pneumococcal vaccine introduction: A population-based cross-sectional study in South Western Uganda, 2014. Vaccine. 2017;35:5271–7.

Hammitt LL, Akech DO, Morpeth SC, Karani A, Kihuha N, Nyongesa S, et al. Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Global Health. 2014;2:e397–405.

Article  PubMed  Google Scholar 

Heinsbroek E, Tafatatha T, Phiri A, Swarthout TD, Alaerts M, Crampin AC, et al. Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination. Vaccine. 2018;36:7369–76.

Article  PubMed  PubMed Central  Google Scholar 

Clifford S, Knoll MD, O’Brien KL, Pollington TM, Moodley R, Prieto-Merino D et al. Global landscape of Streptococcus pneumoniae serotypes colonising healthy individuals worldwide before vaccine introduction; a systematic review and meta-analysis. 2023;:2023.03.09.23287027.

Cohen R, Cohen JF, Chalumeau M, Levy C. Impact of pneumococcal conjugate vaccines for children in high- and non–high-income countries. Expert Rev Vaccines. 2017;16:625–40.

Article  CAS  PubMed  Google Scholar 

Flasche S, Hoek AJV, Sheasby E, Waight P, Andrews N, Sheppard C, et al. Effect of Pneumococcal Conjugate Vaccination on Serotype-Specific Carriage and Invasive Disease in England: a cross-sectional study. PLoS Med. 2011;8:e1001017.

Article  PubMed  PubMed Central  Google Scholar 

Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen SRM, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Infect Dis. 2018;18:1191–210.

Article  Google Scholar 

Murad C, Dunne EM, Sudigdoadi S, Fadlyana E, Tarigan R, Pell CL, et al. Pneumococcal carriage, density, and co-colonization dynamics: a longitudinal study in Indonesian infants. Int J Infect Dis. 2019;86:73–81.

Article  CAS  PubMed  Google Scholar 

Abdullahi O, Karani A, Tigoi CC, Mugo D, Kungu S, Wanjiru E, et al. The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya. PLoS ONE. 2012;7:e30787.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lupien A, Gingras H, Bergeron MG, Leprohon P, Ouellette M. Multiple mutations and increased RNA expression in tetracycline-resistant Streptococcus pneumoniae as determined by genome-wide DNA and mRNA sequencing. J Antimicrob Chemother. 2015;70:1946–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ousmane S, Diallo BA, Ouedraogo R. Genetic determinants of Tetracycline Resistance in Clinical Streptococcus pneumoniae serotype 1 isolates from Niger. Antibiotics. 2018;7:19.

Article  CAS  PubMed